2-(5-bromo-2-methyl-1H-indol-3-yl)-N-[(4-methoxyphenyl)methyl]ethanamine;hydrochloride
C19H22BrClN2O — CID 122187867
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(5-bromo-2-methyl-1H-indol-3-yl)-N-[(4-methoxyphenyl)methyl]ethanamine;hydrochloride
2-(5-bromo-2-methyl-1H-indol-3-yl)-N-[(4-methoxyphenyl)methyl]ethanamine;hydrochloride (PubChem CID 122187867) has the molecular formula C19H22BrClN2O and a molecular weight of 409.76 g/mol. Its IUPAC name is 2-(5-bromo-2-methyl-1H-indol-3-yl)-N-[(4-methoxyphenyl)methyl]ethanamine;hydrochloride.
Molecular Properties
| Compound Name | 2-(5-bromo-2-methyl-1H-indol-3-yl)-N-[(4-methoxyphenyl)methyl]ethanamine;hydrochloride |
|---|---|
| PubChem CID | 122187867 |
| Molecular Formula | C19H22BrClN2O |
| Molecular Weight | 409.76 g/mol |
| Exact Mass | 408.06 |
| IUPAC Name | 2-(5-bromo-2-methyl-1H-indol-3-yl)-N-[(4-methoxyphenyl)methyl]ethanamine;hydrochloride |
| SMILES | COc1ccc(CNCCc2c(C)[nH]c3ccc(Br)cc23)cc1.Cl |
| InChI | InChI=1S/C19H21BrN2O.ClH/c1-13-17(18-11-15(20)5-8-19(18)22-13)9-10-21-12-14-3-6-16(23-2)7-4-14;/h3-8,11,21-22H,9-10,12H2,1-2H3;1H |
| InChIKey | TYZSKHAREJOBRJ-UHFFFAOYSA-N |
| XLogP | 5.00 |
| TPSA | 37.05 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 409.76 |
| LogP ≤ 5 | 5.00 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122187867 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.